
Arcticzymes Technologies ASA
OSE:AZT

Arcticzymes Technologies ASA
Free Cash Flow
Arcticzymes Technologies ASA
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Arcticzymes Technologies ASA
OSE:AZT
|
Free Cash Flow
-kr7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
![]() |
Hofseth Biocare ASA
OSE:HBC
|
Free Cash Flow
-kr13.9m
|
CAGR 3-Years
48%
|
CAGR 5-Years
23%
|
CAGR 10-Years
15%
|
|
B
|
Bergenbio ASA
OSE:BGBIO
|
Free Cash Flow
-kr153.2m
|
CAGR 3-Years
20%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
Free Cash Flow
-kr96m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
Free Cash Flow
-$51.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
T
|
Thor Medical ASA
OSE:TRMED
|
Free Cash Flow
-kr27.6m
|
CAGR 3-Years
59%
|
CAGR 5-Years
40%
|
CAGR 10-Years
3%
|
Arcticzymes Technologies ASA
Glance View
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

See Also
What is Arcticzymes Technologies ASA's Free Cash Flow?
Free Cash Flow
-7.8m
NOK
Based on the financial report for Dec 31, 2024, Arcticzymes Technologies ASA's Free Cash Flow amounts to -7.8m NOK.
What is Arcticzymes Technologies ASA's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-7%